Cargando…
Learning while treating: Gain-of-function STAT6 variants in severe allergic disease
In an era of rapid identification of inborn errors of immunity, Sharma et al.(1) report novel heterozygous gain-of-function variants in the signal transducer and activator of transcription 6 (STAT6) gene in individuals with severe and early onset multi-systemic allergic disease.
Autores principales: | Smith, Tukisa D., Doherty, Taylor A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213836/ https://www.ncbi.nlm.nih.gov/pubmed/37196636 http://dx.doi.org/10.1016/j.xcrm.2023.101040 |
Ejemplares similares
-
Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease
por: Sharma, Mehul, et al.
Publicado: (2023) -
Optimizing hormone therapy for breast cancer: Translating gains to the early-stage setting
por: Chien, A. Jo, et al.
Publicado: (2022) -
Neoadjuvant therapy gains FDA approval in non-small cell lung cancer
por: Leal, Ticiana A., et al.
Publicado: (2022) -
Breaching septal veins while attempting left bundle branch area pacing. If necessary, septography contrast should be injected in a stepwise approach
por: Ferrari, Andrés Di Leoni, et al.
Publicado: (2023) -
Bridging the gap: Short structural variants in the genetics of anorexia nervosa
por: Berthold, Natasha, et al.
Publicado: (2022)